User: Guest

NGS-BASED RNA-SEQ

Global Market Trajectory & Analytics

MCP13599

VALIDATED EXECUTIVE ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

3213

Interactions with Platform & by Email *

INTERACTIONS

579

Unique # Participated *

PARTICIPANTS

96

Responses Validated *

VALIDATIONS

43

* Login to view program details and full enterprise executive list.


  •  DATE

    JULY 2020

  •  TABLES

    142

  •  PAGES

    218

  •  EDITION

    9

  •  PRICE

    USD $5450


COVID-19 IMPACT SURVEY
Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027.Sample Preparation, one of the segments analyzed in the report, is projected to grow at a 16% CAGR to reach US$998.2 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period. This segment currently accounts for a 36.2% share of the global NGS-based RNA-seq market.
The NGS-based RNA-seq market in the U.S. is estimated at US$438 Million in the year 2020. The country currently accounts for a 29.6% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$918.6 Million in the year 2027 trailing a CAGR of 19.3% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR while Rest of European market (as defined in the study) will reach US$918.6 Million by the year 2027.
In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$654.6 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 218-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others, Agilent Technologies, Inc.; Eurofins Scientific; F. Hoffmann-La Roche AG; GATC Biotech AG; Illumina, Inc.; Macrogen, Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; PerkinElmer, Inc.; Qiagen NV; Thermo Fisher Scientific, Inc.
» Application (De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics, Small RNA Sequencing) » End-Use (Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses) » Products & Services (Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services, Data Analysis, Storage, and Management) » Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing, Nanopore Sequencing)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

  • A: 
    ACTIVE CLIENT
  • B: 
    INACTIVE CLIENT
  • C: 
    ACTIVE PANELIST
  • D: 
    INACTIVE PANELIST
  • E: 
    OPT-INS
  
REPORT INDEX PROJECT COMPENDIUM * EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com